全文获取类型
收费全文 | 1214305篇 |
免费 | 111291篇 |
国内免费 | 5076篇 |
学科分类
医药卫生 | 1330672篇 |
出版年
2021年 | 11077篇 |
2020年 | 10904篇 |
2019年 | 11001篇 |
2018年 | 19384篇 |
2017年 | 16414篇 |
2016年 | 18669篇 |
2015年 | 20099篇 |
2014年 | 31584篇 |
2013年 | 40322篇 |
2012年 | 40539篇 |
2011年 | 42792篇 |
2010年 | 31924篇 |
2009年 | 34034篇 |
2008年 | 40284篇 |
2007年 | 40652篇 |
2006年 | 43244篇 |
2005年 | 39144篇 |
2004年 | 37634篇 |
2003年 | 34987篇 |
2002年 | 33792篇 |
2001年 | 51119篇 |
2000年 | 51228篇 |
1999年 | 43931篇 |
1998年 | 15556篇 |
1997年 | 13905篇 |
1996年 | 13081篇 |
1995年 | 13166篇 |
1994年 | 11289篇 |
1993年 | 10325篇 |
1992年 | 33755篇 |
1991年 | 33027篇 |
1990年 | 32228篇 |
1989年 | 31136篇 |
1988年 | 28287篇 |
1987年 | 28294篇 |
1986年 | 26387篇 |
1985年 | 25471篇 |
1984年 | 19096篇 |
1983年 | 16146篇 |
1982年 | 10005篇 |
1979年 | 17184篇 |
1978年 | 12593篇 |
1977年 | 10719篇 |
1976年 | 9990篇 |
1975年 | 10453篇 |
1974年 | 12548篇 |
1973年 | 12090篇 |
1972年 | 11167篇 |
1971年 | 10319篇 |
1970年 | 9613篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
71.
Usha Patel Manish Pandey Sadhana Kannan Tanuja A. Samant Poonam Gera Neha Mittal Swapnil Rane Asawari Patil Vanita Noronha Amit Joshi Vijay M. Patil Kumar Prabhash Manoj B. Mahimkar 《British journal of cancer》2020,123(12):1757
Background Anti-EGFR-based therapies have limited success in HNSCC patients. Predictive biomarkers are greatly needed to identify the patients likely to be benefited from these targeted therapies. Here, we present the prognostic and predictive association of biomarkers in HPV-negative locally advanced (LA) HNSCC patients.Methods Treatment-naive tumour tissue samples of 404 patients, a subset of randomised Phase 3 trial comparing cisplatin radiation (CRT) versus nimotuzumab plus cisplatin radiation (NCRT) were analysed to evaluate the expression of HIF1α, EGFR and pEGFR by immunohistochemistry and EGFR gene copy change by FISH. Progression-free survival (PFS), locoregional control (LRC) and overall survival (OS) were estimated by Kaplan–Meier method. Hazard ratios were estimated by Cox proportional hazard models.Results Baseline characteristics of the patients were balanced between two treatment groups (CRT vs NCRT) and were representative of the trial cohort. The median follow-up was of 39.13 months. Low HIF1α was associated with better PFS [HR (95% CI) = 0.62 (0.42–0.93)], LRC [HR (95% CI) = 0.56 (0.37–0.86)] and OS [HR (95% CI) = 0.63 (0.43–0.93)] in the CRT group. Multivariable analysis revealed HIF1α as an independent negative prognostic biomarker. For patients with high HIF1α, NCRT significantly improved the outcomes [PFS:HR (95% CI) = 0.55 (0.37–0.82), LRC:HR (95% CI) = 0.55 (0.36–0.85) and OS:HR (95% CI) = 0.54 (0.36–0.81)] compared to CRT. While in patients with low HIF1α, no difference in the clinical outcomes was observed between treatments. Interaction test suggested a predictive value of HIF1α for OS (P = 0.008).Conclusions High HIF1α expression is a predictor of poor clinical response to CRT in HPV-negative LA-HNSCC patients. These patients with high HIF1α significantly benefited with the addition of nimotuzumab to CRT.Clinical trial registration Registered with the Clinical Trial Registry of India (Trial registration identifier—CTRI/2014/09/004980).Subject terms: Tumour biomarkers, Head and neck cancer, Tumour biomarkers, Head and neck cancer, Predictive markers 相似文献
72.
73.
74.
Dermoscopic difficult lesions: an objective evaluation of reflectance confocal microscopy impact for accurate diagnosis 下载免费PDF全文
75.
76.
77.
78.
Lois Isaksen MD 《Academic emergency medicine》2015,22(9):1125-1126
79.
Mark Koday DDS Stephen Davis DDS Molly Melbye DDS MPH 《Journal of public health dentistry》2020,80(Z2):S114-S116
The Yakima Valley Farm Workers Clinic (YVFWC) is one of the largest community health centers in the country with clinics throughout south-central Washington and northern Oregon. Its dental program consists of 14 dental clinics providing general and specialty services to the low-income populations it serves. Modeling itself after the YVFWC medical managed care program; the Dental program recently added value-based metrics to its dental practice after Oregon offered a value-based dental reimbursement plan in 2019. This is the first-step YVFWC's dental program that has taken to prepare for value-based reimbursement and transform its dental practice in order to reduce the disease burden in its patient population. The purpose of this article is to describe the processes YVFWC undertook to prepare itself for the new reimbursement model, which included the development of metrics, a metric validation process, a clinical dashboard, and a method for improving metrics. It also outlines its medical/dental integration improvement brought about by embedding hygienists into the medical primary care teams. 相似文献
80.